Pentasa and cough Patient Reports February 13, 2012

Pentasa Side Effects Report #4865841-5
Pentasa side effect was reported by a Consumer or non-health professional from FRANCE on Dec 06, 2005. Female patient, 47 years of age, was diagnosed with inflammatory bowel disease and was treated with Pentasa. After drug was administered, patient experienced the following side effects: arthralgia, asthenia, blood alkaline phosphatase increased, blood amylase increased, blood creatinine increased, chest pain , cholelithiasis, cough, crepitations. Pentasa dosage: unknown. During the same period patient was treated with CHLORMADINONE ACETATE, MONTMORILLONITE, PROPRANOLOL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5127656-2
Pentasa side effect was reported by a Consumer or non-health professional from JAPAN on Sept 27, 2006. Male patient, 16 years of age, was diagnosed with crohn's disease  and was treated with Pentasa. After drug was administered, patient experienced the following side effects: cough, diarrhoea, eosinophilic pneumonia, pyrexia. Pentasa dosage: 500 MG, 3X/DAY:TID, ORAL. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #4630258-5
Pentasa side effect was reported by a Consumer or non-health professional from on Mar 25, 2005. Male patient, 73 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: chills, cough, interstitial lung disease, lymphocyte percentage decreased, neutrophil percentage decreased, pulmonary fibrosis , weight decreased. Pentasa dosage: unknown. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5292053-6
Pentasa side effect was reported by a Health Professional from POLAND on Mar 19, 2007. Male patient, 35 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: anaemia, asthenia, colitis ulcerative, condition aggravated, cough, haematochezia, hyperglycaemia, lung disorder. Pentasa dosage: unknown. During the same period patient was treated with SULFASALAZINE. Patient recovered.


Pentasa Side Effects Report #5330578-5
Pentasa side effect was reported by a Health Professional from POLAND on May 10, 2007. Male patient, 35 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, asthenia, chest x-ray abnormal, cough, hyperglycaemia, lung infiltration, night sweats. Pentasa dosage: unknown. During the same period patient was treated with SULFASALAZINE. Patient recovered.

Pentasa Side Effects Report #5124931-2
Pentasa side effect was reported by a Consumer or non-health professional from JAPAN on Sept 22, 2006. Female patient, 31 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: cough, pericardial effusion, pericarditis, pharyngolaryngeal pain, pleural effusion, pleurisy, pyrexia. Pentasa dosage: 750 MG, 3X/DAY; TID; ORAL. During the same period patient was treated with CEFAMEZIN, CEFDINIR. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #4827418-7
Pentasa side effect was reported by a Consumer or non-health professional from JAPAN on Oct 27, 2005. Female patient, 25 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: c-reactive protein increased, cough, diarrhoea haemorrhagic, dyspnoea, eosinophil percentage increased, haemoglobin decreased, pleural effusion, pleurisy. Pentasa dosage: 2250 MG/DAY, ORAL. During the same period patient was treated with TIQUIZIUM BROMIDE, LOXOPROFEN. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #4634663-2
Pentasa side effect was reported by a Consumer or non-health professional from on Mar 29, 2005. Female patient, 16 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: alveolitis allergic, cough, pharyngolaryngeal pain, pyrexia. Pentasa dosage: 750 MG, 3X/DAY, TID, ORAL. Patient was hospitalized. Patient recovered.